BUPIVACAINA SPINAL HEAVY PANPHARMA 5mg / ml injectible solution medication leaflet

N01BB01 bupivacaine • Nervous system | Anesthetics, local | Amides

Bupivacainum is a local anesthetic commonly used for regional anesthesia and pain control during surgical procedures, childbirth, or other medical interventions. It works by blocking sodium channels in nerve cell membranes, thereby inhibiting the transmission of pain signals to the brain.

The medication is administered via epidural, spinal, or local injection, as directed by a doctor. The dosage and method of administration are adjusted based on the type of procedure and the patient's condition.

Common side effects include low blood pressure, nausea, dizziness, and headaches. In rare cases, more severe adverse effects such as systemic toxicity, which can affect the central nervous and cardiovascular systems, may occur.

Bupivacainum is not recommended for pregnant or breastfeeding women unless absolutely necessary and under strict medical supervision. Patients should inform their doctor about any other medications they are taking to avoid drug interactions. Additionally, administration should be performed by qualified medical personnel to minimize the risks associated with the use of this anesthetic.

General data about BUPIVACAINA SPINAL HEAVY PANPHARMA 5mg / ml

Substance: bupivacaine

Date of last drug list: 01-06-2025

Commercial code: W68634002

Concentration: 5mg / ml

Pharmaceutical form: injectible solution

Packing volume: 4 ml

Product type: generic

Price: 64.04 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PANPHARMA GMBH - GERMANIA

Holder: PANPHARMA - FRANTA

Number: 14325/2022/02

Shelf life: 2 years - dupa ambalare pt comercializare; after the first opening a fiolei - it is used immediately

Concentrations available for bupivacaine

2.5mg/ml, 25mg/10ml, 50mg/10ml, 5mg/ml